NASDAQ : XWEL
XWELL, Inc. — Key statistics
Healthcare · Diagnostics & Research · United States
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 6.15M |
| Enterprise Value | 1.66M |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 13, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 8.59M |
| Shares Outstanding | 8.59M |
| Shares Change (YoY) | +32.23% |
| Shares Change (QoQ) | +14.75% |
| Owned by Insiders (%) | 26.32% |
| Owned by Institutions (%) | 22.40% |
| Float | 5.81M |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.22 |
| Forward PS | n/a |
| PB Ratio | 0.74 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | 0.06 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 2.27 |
| Quick Ratio | 2.04 |
| Debt / Equity | 0.88 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -337.03 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | -361.36% |
| Return on Assets (ROA) | -31.37% |
| Return on Invested Capital (ROIC) | -403.18% |
| Return on Capital Employed (ROCE) | -77.83% |
| Weighted Average Cost of Capital (WACC) | 4.48% |
| Revenue Per Employee | $101,007 |
| Profits Per Employee | -$119,014 |
| Employee Count | 280 |
| Asset Turnover | 1.32 |
| Inventory Turnover | 39.05 |
Taxes
| Measure | Value |
|---|
| Income Tax | 46,000 |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 0.93 |
| 52-Week Price Change | -19.07% |
| 50-Day Moving Average | 0.85 |
| 200-Day Moving Average | 1.01 |
| Relative Strength Index (RSI) | 42.44 |
| Average Volume (20 Days) | 59,179 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 117,363 |
| Short Previous Month | 143,228 |
| Short % of Shares Out | 1.37% |
| Short % of Float | 2.02% |
| Short Ratio (days to cover) | 2.73 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 28.28M |
| Gross Profit | 9.71M |
| Operating Income | -10.79M |
| Pretax Income | -22.32M |
| Net Income | -33.32M |
| EBITDA | -9.94M |
| EBIT | -10.79M |
| Loss Per Share | -$4.86 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 11.78M |
| Total Debt | 7.29M |
| Net Cash | 4.49M |
| Net Cash Per Share | $0.52 |
| Equity (Book Value) | 8.25M |
| Book Value Per Share | -0.22 |
| Working Capital | 8.47M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | -11.27M |
| Capital Expenditures | -2.21M |
| Depreciation & Amortization | 844,000 |
| Net Borrowing | n/a |
| Free Cash Flow | -13.48M |
| FCF Per Share | -$1.57 |
Margins
| Measure | Value |
|---|
| Gross Margin | 34.35% |
| Operating Margin | -38.13% |
| Pretax Margin | -78.90% |
| Profit Margin | -82.90% |
| EBITDA Margin | -35.15% |
| EBIT Margin | -38.13% |
| FCF Margin | n/a |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -32.23% |
| Shareholder Yield | -32.23% |
| Earnings Yield | -679.09% |
| FCF Yield | -219.29% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | Sep 28, 2023 |
| Split Type | Reverse |
| Split Ratio | 1:20 |
Scores
| Measure | Value |
|---|
| Altman Z-Score | -33.86 |
| Piotroski F-Score | 4 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |